| NewAmsterdam Pharma Co N.V. | NAMS | Johannes Jacob Pieter KasteleinChiefDERIV | Sep 30 | MPLAN | 50,246 | $0.00 | —? |
| NewAmsterdam Pharma Co N.V. | NAMS | Johannes Jacob Pieter KasteleinChief | Sep 30 | SPLAN | 50,246 | $25.03 | $1.3M |
| NewAmsterdam Pharma Co N.V. | NAMS | Johannes Jacob Pieter KasteleinChief | Sep 30 | MPLAN | 50,246 | — | — |
| NewAmsterdam Pharma Co N.V. | NAMS | Johannes Jacob Pieter KasteleinChiefDERIV | Aug 24 | MPLAN | 125,000 | $0.00 | —? |
| NewAmsterdam Pharma Co N.V. | NAMS | Johannes Jacob Pieter KasteleinChief | Aug 24 | SPLAN | 125,000 | $26.91 | $3.4M |
| NewAmsterdam Pharma Co N.V. | NAMS | Johannes Jacob Pieter KasteleinChief | Aug 24 | MPLAN | 125,000 | — | — |
| NewAmsterdam Pharma Co N.V. | NAMS | Johannes Jacob Pieter KasteleinChiefDERIV | Mar 9 | MPLAN | 101,409 | $0.00 | —? |
| NewAmsterdam Pharma Co N.V. | NAMS | Johannes Jacob Pieter KasteleinChiefDERIV | Mar 6 | MPLAN | 94,124 | $0.00 | —? |
| NewAmsterdam Pharma Co N.V. | NAMS | Johannes Jacob Pieter KasteleinChiefDERIV | Mar 5 | MPLAN | 104,467 | $0.00 | —? |
| NewAmsterdam Pharma Co N.V. | NAMS | Johannes Jacob Pieter KasteleinChief | Mar 9 | SPLAN | 101,409 | $30.29 | $3.1M |
| NewAmsterdam Pharma Co N.V. | NAMS | Johannes Jacob Pieter KasteleinChief | Mar 9 | MPLAN | 101,409 | — | — |
| NewAmsterdam Pharma Co N.V. | NAMS | Johannes Jacob Pieter KasteleinChief | Mar 6 | SPLAN | 94,124 | $30.32 | $2.9M |
| NewAmsterdam Pharma Co N.V. | NAMS | Johannes Jacob Pieter KasteleinChief | Mar 6 | MPLAN | 94,124 | — | — |
| NewAmsterdam Pharma Co N.V. | NAMS | Johannes Jacob Pieter KasteleinChief | Mar 5 | SPLAN | 104,467 | $30.30 | $3.2M |
| NewAmsterdam Pharma Co N.V. | NAMS | Johannes Jacob Pieter KasteleinChief | Mar 5 | MPLAN | 104,467 | — | — |
| NewAmsterdam Pharma Co N.V. | NAMS | Johannes Jacob Pieter KasteleinChief | Feb 20 | S | 30,789 | $35.46 | $1.1M |
| NewAmsterdam Pharma Co N.V. | NAMS | Johannes Jacob Pieter KasteleinChief | Feb 20 | S | 14,692 | $35.00 | $514K |
| NewAmsterdam Pharma Co N.V. | NAMS | Johannes Jacob Pieter KasteleinChiefDERIV | Jan 7 | APLAN | 115,000 | $0.00 | —? |
| NewAmsterdam Pharma Co N.V. | NAMS | Johannes Jacob Pieter KasteleinChief | Jan 7 | APLAN | 25,500 | — | — |
| NewAmsterdam Pharma Co N.V. | NAMS | Johannes Jacob Pieter KasteleinChief | Jan 5 | SPLAN | 6,000 | $33.25 | $200K |